(1R,2R)-2-Iodocyclopropanecarboxylic acid, 95.0%, 250mg

1,2,4-Triazolo[4,3-a]pyridine, 6-[4-(trifluoromethoxy)phenyl]-3-(trifluoromethyl)-, 5mg

(3,5-Dibromothiophen-2-yl)methanol, 100mg

tert-Butyl 3-iodobenzoate, 95.0%, 5g

2,3-Dibromo-4-methylpyridine, 95.0%, 5g

5-(5-Methoxy-2-bromophenyl)-1,3-oxazole, 98%, 1g

4-(3-Fluoro-phenylsulfanylmethyl)-piperidine-1-carboxylic acid tert-butyl ester, 95.0%, 1g

(1-isobutyl-1H-pyrazol-4-yl)methylamine, 1g

Round bottom flask with standard ground joint 6000 ml NS 45/40

Dacomitinib>98.0%(HPLC)50mg

2-(Difluoromethyl)-1,3-difluorobenzene, 98.0%, 1g

4-chloro-2-methylpyrazolo[1,5-a]pyrazine, 95.0%, 100mg

3-Methoxypyridin-4-amine, 95.0%, 1g